Introduction {#Sec1}
============

Diarrhea represents the third leading cause of child morbidity and mortality in the world, with serious impacts on public health policies and economies, particularly of lower-income countries \[[@CR1]\]. Enterotoxigenic *Escherichia coli* (ETEC) remains an important etiological agent of diarrheal illness in childhood and is the most common cause of traveler's diarrhea \[[@CR1]--[@CR4]\]. The disease developed by ETEC strains requires the production of colonization factors (CFs), responsible for bacterial adhesion to enterocytes, as well as heat-stable toxins (ST) and/or heat-labile toxins (LT) \[[@CR5], [@CR6]\]. LT alone, or in combination with ST, is expressed by more than half of the ETEC isolates \[[@CR7], [@CR8]\]. Once produced and released into the small intestine, LT binds to host cells via the pentameric B subunit, which leads to increased intracellular cyclic adenosine monophosphate (cAMP) levels due to indirect enzymatic activity of the A subunit, causing water/electrolyte losses and, thereby, watery diarrhea of different severities \[[@CR5], [@CR6]\].

Although clonal and stable lineages of ETEC are spread worldwide, epidemiological studies have revealed high genetic and phenotypic diversity among ETEC strains regarding serotypes, virulence features, mainly CFs and LT types, and genotypes disclosed by molecular approaches \[[@CR7], [@CR9]--[@CR14]\]. Our group previously showed the occurrence of 16 LT types among ETEC strains derived from asymptomatic and diarrheic Brazilian children \[[@CR11]\]. These LT types were grouped into four phylogenetic clusters, two of which (A and D) comprised the majority of the variants closely related to the types LT1 and LT2, respectively. More recently, these results were confirmed by further studies, and twelve additional LT variants were found among clinical strains isolated from diverse geographic areas \[[@CR12]\]. Genetic polymorphisms in noncoding regulatory sequences and in LT-structural genes have also been ascribed to different LT types \[[@CR11], [@CR12], [@CR14]\]. However, considering the data available in the literature, thus far it has not been possible to correlate the ability to express LT and the natural genetic polymorphisms detected among different LT types.

LT expression and secretion are also variable traits observed among ETEC strains \[[@CR12], [@CR15]--[@CR17]\]. The amount of toxin secreted by strains producing only LT correlates with the severity of diarrhea in animal models and depends on the capability of the bacteria to produce and release the toxin \[[@CR15]\]. LT expression is affected by different growth conditions, such as temperature, pH, osmolarity, and the presence of glucose, which indicates the presence of diverse regulation mechanisms \[[@CR18], [@CR19]\].

The A and B subunits of LT are encoded by the *eltA* and *eltB* genes, which are under the control of a single promoter and a transcriptional terminator \[[@CR20]--[@CR22]\]. LT production is repressed by heat-stable nucleoid-structural (H-NS) proteins, which bind a region of DNA near the transcriptional start site and a site at the end of the *eltA* gene \[[@CR22]\]. Under environmental changes, particularly at 37 °C, the DNA-H-NS complex is destabilized, allowing the binding of RNA polymerase, leading to the synthesis of *eltAB* polycistronic mRNA \[[@CR22], [@CR23]\]. In addition, it was reported that the cAMP receptor protein (CRP) negatively regulates LT expression, but there are doubts about the direct binding of this protein to the *eltAB* regulatory region \[[@CR24], [@CR25]**\]**. Posttranslational regulation of LT expression has also been reported, but the available evidence is weak \[[@CR20], [@CR21], [@CR26]\].

In the present study, we demonstrated that specific nucleotide changes at the promoter region of the *eltAB* operon impact LT expression among clinically derived ETEC strains of different phylogenetic clusters. In addition, our results revealed that LT stability is affected by posttranscriptional mechanisms, which demonstrate that intrinsic transcriptional and posttranscriptional factors contribute to the strain-specific LT expression observed among ETEC strains.

Materials and methods {#Sec2}
=====================

Bacterial strains and growth conditions {#Sec3}
---------------------------------------

The LT-producing ETEC strains listed in Table [1](#Tab1){ref-type="table"} were previously characterized regarding genetic and phenotypic features \[[@CR10], [@CR11], [@CR15]\]. The H10407 (LT^+^ST^+^CFA-I^+^) is the most studied ETEC strain, particularly in regard to sequencing data and regulation mechanism of the *eltAB* operon, and, therefore, it was used as a reference strain. The H10407 strain was kindly provided by Ann-Mari Svennerholm (University of Gothenburg, Gothenburg, Sweden). The BL21 competent *E. coli* were transformed with plasmids harboring the transcriptional fusions or with a control plasmid, generating the recombinant strains. The bacterial strains were cultivated in CA-YE medium (2% casamino acids, 0.6% yeast extract, 43 mM NaCl, 38 mM K~2~HPO~4~, and 0.1% trace salt solution consisting of 203 mM MgSO~4~, 25 mM MnCl~2~, and 18 mM FeCl~3~; pH = 8.4) at 37 °C and 200 rpm \[[@CR27]\].Table 1Phenotypic and genotypic features of LT-producing ETEC strains analyzed in the present studyStrainSource^*a*^SerotypeLT TypeLT Group^*c*^*eltAB* promoter polymorphisms^*d*^- 14- 7H10407DCO78:H11LT1A, I**GC**136IDCO88:H25LT3^*b*^C, III**GT**136IIIDCO88:H25LT3136IIDCO88:H25LT536IIIDCO159:H21LT2D, II**TT**36IVDCO159:H21LT2187 VDCO159:H21LT263 VACO159:H17LT14^a^*AC* asymptomatic child, *DC* diarrheic child^b^LT variants with (LT3) or without (LT5) the polymorphic site R13H in the B subunit^c^Phylogenetic relationship of the LT-I types according to Lasaro et al. (2008) and Joffré et al. (2015)^d^Polymorphisms in the *eltAB* promoter region at the positions − 14 and − 7, according to the transcription start site, using H10407 as reference ETEC

Sequencing and phylogenetic analyses {#Sec4}
------------------------------------

The DNA sequences upstream of the translation start codon of the *eltA* gene, comprising 334 nucleotides, were amplified by PCR using genomic DNA from ETEC strains and sequenced by the Sanger method (ABI 3100 sequencer, Big Dye version 1, PerkinElmer Applied Biosystems) as previously described \[[@CR11]\]. The forward and reverse primers for PCR and sequencing were constructed based on the sequence of the *eltAB* operon from plasmid p666 (GenBank: FN649417.1), and their sequences are described in Table [2](#Tab2){ref-type="table"}. Representative nucleotide sequences for each polymorphic group were deposited in GenBank: MN163050 (136I), MN163051 (36III), MN163052 (187 V). The phylogenetic relationship among the ETEC strains based on the sequenced regulatory nucleotides was represented by a rooted tree generated using the ClustalW program and neighbor-joining methods.Table 2Oligonucleotides used in the present studyOligonucleotideSequenceFwRT*rpoA*^\*^5´-AAGCTGGTCATCGAAATGGA-3´RvRT*rpoA*5´-GCCGCACGACGAATCG-3´FwRT*eltB*5´-GGCAGGCAAAAGAGAAATGG-3´RvRT*eltB*5´-CGGGACTTCGACCTGAAATG-3´FwCRP*Kpn*I^\*\*^5´-GGTGGGTACCTTCTGGTGCTC-3′RvPromoter*elt*^\*\*^5´-GACTGTCCTGCTAAGTGAGC-3´^\*^Oligonucleotides labeled as RT were used for real-time PCR. Fw and Rv denote forward and reverse, respectively. The target transcripts for RT-PCR are indicated in the oligonucleotide names^\*\*^Oligonucleotide used for sequencing of the region upstream of the *etxA* gene, corresponding to 334 nucleotides. Underlined nucleotides indicate the *Kpn*I restriction site

Description of the *eltAB*-*gfp* transcriptional fusions and GFP detection assay {#Sec5}
--------------------------------------------------------------------------------

The *eltAB* operon regions from UP elements to the start codon of translation (position − 48 to + 58 according to the transcription start), harboring the *eltAB* promoter observed in the tested ETEC strains, were genetically fused to the DNA sequence encoding the green fluorescent protein (GFP) (GenBank number: KF410615.1). Three *eltAB* promoter-*gfp* gene transcriptional fusions were drawn regarding the polymorphisms observed in the *eltAB* promoters of the ETEC strains using the *eltAB* operon from H10407 as a reference (Table [1](#Tab1){ref-type="table"}). The pBSK(+) vectors harboring the transcriptional fusions were manufactured by the Biomatik Company (Wilmington, Delaware, USA). A plasmid containing the *gfp* gene under the control of the *lepA* promoter was used as a positive control for GFP production. The BL21 *E. coli* strains harboring the plasmids (recombinant strains) or not (mock) were grown in CA-YE medium for 6 h at 37 °C and 200 rpm. Culture aliquots were centrifuged, and the cell sediments were resuspended in phosphate-buffered saline (PBS) 1x, generating bacterial suspensions equivalent to an OD~600\ nm~ of 5. The samples (100 μl/well) were transferred to a microtiter plate in triplicate, and the green fluorescence was detected with excitation at 490 nm and emission at 510--570 nm in a fluorometer (Glomax-Multi Detection System, Promega). The results were expressed as fluorescence arbitrary units.

RNA extraction and RT-PCR {#Sec6}
-------------------------

For RNA isolation, ETEC strains were grown in CA-YE medium to an OD~600\ nm~ of 5.0. Cells were harvested by centrifugation at 16,000 x g for 1 min, and total RNA was extracted by the Trizol method (Invitrogen). RNA samples were treated with DNase I (Fermentas) and tested for the absence of DNA contamination by PCR. RNA quality was evaluated by agarose/formaldehyde gel electrophoresis, and the yield was determined by NanoDrop 2000 (Thermo Fisher Scientific). Reverse transcription was performed using 2.5 μg of RNA, 200 U of RevertAid Reverse Transcriptase (Fermentas), and 200 ng of random hexamer primer (Fermentas). Quantitative PCR amplification of the resulting cDNA was carried out with Maxima SYBR Green/ROX qPCR Master Mix (Fermentas) and 0.4 μM oligonucleotides specific for each gene (Table [2](#Tab2){ref-type="table"}). Primers were designed using the Primer Express Software (Applied Biosystems), and their sequences are described in Table [2](#Tab2){ref-type="table"}. The results obtained with the *eltAB* primers were normalized using the *rpoA* gene as the endogenous control, which was shown to be constant in the samples analyzed. In addition, efficiency analysis of the primers was tested using different amounts of *eltAB*-specific cDNA into the real-time PCR reactions. The *rpoA* gene-specific primers resulted in efficient amplification according to Ct-based standard curve analysis (equation = − 0.9339 × + 17.269; R^2^ = 0.9990). Relative expression levels were calculated using the 2-∆∆CT method \[[@CR28]\].

LT production assay {#Sec7}
-------------------

Measurement of the cell-associated and secreted LT levels among different ETEC strains was based on previously described protocols \[[@CR15], [@CR19]\]. The culture samples of the reference strain H10407 were adjusted to an OD~600\ nm~ equal to 0.1 and allowed to grow in CA-YE medium for 6 h until an OD~600\ nm~ is equivalent to approximately 5.0 or overnight cultures (18 h). The cell samples were adjusted to an OD~600\ nm~ equal to 1 or 5, with samples harvested after 6 h, or to an OD~600\ nm~ of 14, with samples cultivated overnight. After cell lysis, culture supernatants and debris-free extracts of the bacterial pellets were recovered and kept at 4 °C before LT quantification (ng/ml) by ELISA. Alternatively, bacterial strains were cultivated for 6 h, processed without normalizing the culture optical density, and the LT concentrations were adjusted according to the total protein content, which was determined using the Bradford assay. The last protocol allowed us to normalize LT concentration both in the bacterial cell extracts and supernatants and generate LT values from cell extracts similar to those obtained with cellular density adjustments equivalent to 5 (Fig. [S1](#MOESM1){ref-type="media"}, Supplementary Material). For routine analyses of LT expression in the tested ETEC strains, we applied the protocol based on the normalization of LT expression by total protein content. The total LT production for each bacterial strain was calculated according to the following formula: secreted LT + cell-associated LT (ng/ml)/total protein in the supernatant + cell-associated total protein (mg/ml), and the resulting values were expressed by ng of LT/mg of total protein.

LT and total bacterial protein quantifications {#Sec8}
----------------------------------------------

Quantification of LT in the bacterial fractions was performed by capture ELISA as previously described \[[@CR15]\]. Briefly, the microtiter plates (Nunc Maxisorp-Thermo Fisher Scientific, Waltham, Massachusetts, USA) were coated with rabbit anti-cholera toxin serum (titer equal to 1 × 10^6^) diluted to 1:1000 in PBS 1x. After overnight incubation, twofold serial dilutions of the samples were placed on the plates, and the captured LT was detected by serial exposure to mouse anti-LT serum (titer = 5 × 10^4^) and horseradish peroxidase-conjugated goat anti-mouse IgG antibodies (Sigma-Aldrich, St. Louis, MO, USA) diluted to 1:2500 and 1:5000, respectively. The reactions were read at 492 nm in an Epoch™ Multi-Volume Spectrophotometer (BioTek Instruments, Vermont, USA). The Bradford assay was carried out to measure total protein in the bacterial samples according to the manufacturer's instructions (Coomassie Plus Protein Assay Kit, Thermo Fisher Scientific). Standard curves (regression analysis with R^2^ \> 0.98), generated with the absorbance values versus concentrations of purified LT or bovine serum albumin (Pierce-Thermo Fisher Scientific), were used to determine LT and total protein concentrations, respectively, in the samples. Purified LT was obtained as previously reported \[[@CR15]\].

LT stability assay {#Sec9}
------------------

Determination of the LT stability in cell cultures of different ETEC strains was based on a protein synthesis inhibition assay using chloramphenicol \[[@CR29]\]. ETEC strains were grown in CA-YE broth for 6 h, and then the cultures were supplemented with chloramphenicol (100 μg/ml). Alternatively, the bacterial cultures were supplemented with chloramphenicol (100 μg/ml) and a protease inhibitor cocktail according to the manufacturer's instructions (ProteoBlock™ Protease Inhibitor Cocktail, Fermentas, Thermo Fisher Scientific). Aliquots (5 ml) were collected at different times (0, 30, 60, and 90 min), and the bacterial cells were sonicated to release the LT toxin. The LT concentration was measured and normalized according to the total protein concentration. The LT stability was determined according to the following formula: (LT concentration in the cultures after 30--90 min × 100)/LT concentration at 0 h. The resulting values were expressed as percentages.

Statistical analyses {#Sec10}
--------------------

All data were represented as arithmetic means ± SE and analyzed for two-way ANOVA with Tukey's post hoc test using GraphPad Prism v5 software (GraphPad Software, Inc., La Jolla, CA).

Results {#Sec11}
=======

Natural genetic polymorphism of *eltAB* regulatory sequences in ETEC strains {#Sec12}
----------------------------------------------------------------------------

Genetic polymorphisms have been reported in the promoter and upstream regions of the LT1 and LT2 *eltAB* operons in ETEC strains \[[@CR20]\]. We sequenced the region encompassing 334 nucleotides upstream of the translational start codon of the *eltA* gene of 8 ETEC strains expressing 4 different serotypes and 5 different LT types (1, 2, 3, 5, and 14), according to a previously reported classification based on the *eltAB* gene sequences (Table [1](#Tab1){ref-type="table"}) \[[@CR11]\]. According to the Kyoto Encyclopedia of Genes and Genomes (KEGG) (PMID 10592173), this 334 bp region may also contain the promoter elements of the 2 open reading frames (ORFs) divergently transcribed to the *eltAB* operon (Fig. [1A](#Fig1){ref-type="fig"}). The sequence of the ETEC reference strain H10407 was identical to that derived from plasmid p666 and previously deposited in GenBank (GenBank: FN649417.1). Altogether, seven polymorphic sites were found in the sequence upstream of the transcription start site: four were located at presumed nonregulatory DNA sequences (T-229C, A-195G, T-92C, A-78G), two at the promoter region (spacer and Pribnow box: G-14T and C-7T, respectively), and one at the UP regulatory element (deletion at position − 51 from start site of transcription) (Fig. [1A](#Fig1){ref-type="fig"}). Two of these polymorphic sites were not previously reported (A-78G and a deletion at position − 51), and the A-78G polymorphic site was characteristic of strains belonging to the O88 serogroup that express LT3/LT5 types. In addition, no polymorphic sites were found at the previously reported CRP-binding sites \[[@CR24]\]. Based on the determined *eltAB* sequences, the tested strains were grouped into three clusters according to the serotypes and/or LT types (Fig. [1B](#Fig1){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}). As previously shown \[[@CR14]\], our results confirmed the natural genetic polymorphism in the *eltAB* transcriptional regulatory elements among LT1- and LT2-producing ETEC strains and, for the first time, also among strains encoding LT3, LT5, and LT14 types.Fig. 1Polymorphism in the *eltAB* promoter region among ETEC strains and the modifications on the promoter activity. (**A**) Alignment of the nucleotide sequences upstream of the translation start codon of the *eltA* genes from different ETEC strains obtained by Sanger sequencing. The transcription start site is indicated by an arrow as previously shown (Bodero and Munson, 2009). The − 35 and − 10 regions of the *eltAB* promoter, as well as the ribosome binding site, are marked with boxes. The sequence from the H10407 strain used in our experiments, which is identical to that deposited in GenBank (FN649417.1), was used as a reference, and the nucleotide changes are indicated below for other ETEC strains. A schematic representation of the *eltAB* operon and genes divergently transcribed is shown above, and the intergenic regions are highlighted in the sequence alignment. (**B**) Phylogenetic tree constructed from the sequences showed to Fig. 1A using the ClustalW program. (**C**) Left panel: schematic representation of the *elt-gfp* transcriptional fusions. The *lepA-gfp* fusion was used as a positive control for GFP expression in the laboratory *E. coli* strain (GFP Ctrl). (**C**) Right panel: measurement of GFP fluorescence. The original nontransformed *E. coli* strain (without *gfp* gene) was used as negative control (Mock). The values represent the means ± SE from three independent experiments. \*\*\**p* \< 0.001 and \*\*\*\* *p* \< 0.0001, significant differences with regard to the Mock group and between values indicated by brackets (two-way ANOVA with Tukey's test)

The impact of sequence polymorphism on the transcriptional activity of *eltAB* genes {#Sec13}
------------------------------------------------------------------------------------

The impact of the observed sequence polymorphisms on the transcriptional activity of the *elt* operon was determined after cloning a reporter gene downstream of the *eltAB* promoter. The transcriptional fusions were constructed by combining the nucleotide changes at positions − 14 and − 7 (G-14 T and C-7 T): P*eltAB*(G-14, C-7), from the reference strain H10407, P*eltAB*(H10407), P*eltAB*(C-7 T), and P*eltAB*(G-14 T, C-7 T) (Fig. [1](#Fig1){ref-type="fig"}). The recombinant *E. coli* strains harboring the transcriptional fusions showed similar growth patterns to the nontransformed *E. coli* (data not shown). The presence of P*eltAB*(H10407) resulted in a two- to fourfold increase in GFP production compared to the expression observed with P*eltAB*(G-14 T, C-7 T) and P*eltAB*(C-7 T), respectively (Fig. [1C](#Fig1){ref-type="fig"}). These results indicate that the tested nucleotide changes affected the transcriptional activity of the *eltAB* genes. To confirm these findings, we monitored the production of LT-specific mRNA in different ETEC strains. In our experimental conditions, with the primers designed for *rpoA,* a housekeeping gene, and for *eltB*, as the target gene (FwRT*eltB* and RvRT*eltB*), we observed clear correlations among Ct values and the amounts of cDNA (Table [2](#Tab2){ref-type="table"}, Fig. [2A and B](#Fig2){ref-type="fig"}). Based on this set of primers, the levels of *eltB*-specific transcripts in the H10407 strain were approximately 4- and 12-fold higher than those expressed by the tested O159- or O88-associated ETEC strains, which harbor P*eltAB*(G-14 T, C-7 T) and P*eltAB*(C-7 T), respectively (Figs. [1](#Fig1){ref-type="fig"} and [2C](#Fig2){ref-type="fig"}). Similar to the results generated with the operon fusion experiments, it was possible to demonstrate that the observed sequence polymorphisms in the promoter sequence affected the *elt* operon transcriptional regulation in all tested ETEC strains. Additionally, ETEC strains sharing the same serotype/serogroup showed similar transcriptional regulation of the *eltAB* operon.Fig. 2LT-specific transcription among different ETEC strains. (**A** and **B**) Evaluation of primer efficiency on the detection of *eltB* (**A**) and *rpoA* (**B**) expression. Different amounts of specific cDNA from H10407 ETEC were used for the RT-PCR. (**C**) Expression of LT-specific mRNA measured by RT-PCR among ETEC strains harboring different *eltAB* promoter regions: P*eltAB*(H10407) (white bars), P*eltAB*(G-14 T, C-7 T) (black bars), and P*eltAB*(C-7 T) (gray bars). The values represent the means ± SE from two independent experiments. \* *p* \< 0.01, significant difference with regard to the values represented by the gray bars, and \*\*\* *p* \< 0.001, significant differences with regard to the values represented by the black and gray bars (two-way ANOVA with Tukey's test)

Posttranscriptional factors affecting LT expression {#Sec14}
---------------------------------------------------

We also determined the action of posttranscriptional regulatory factors by measuring the amount and stability of LT produced by the different ETEC strains. For that purpose, we standardized the quantification using the total protein content present in both bacterial cell lysates and culture supernatants as a reference to measure the amount of cell-associated and secreted LT level (see [Materials and Methods](#Sec2){ref-type="sec"}, Fig. [S1](#MOESM1){ref-type="media"}, Supplementary Material). The total amount of LT produced by the tested ETEC strains ranged from 64 to 177 ng of toxin/mg of total protein, which included both cell-associated and secreted toxin (Fig. [3](#Fig3){ref-type="fig"}). Similar to the results based on the measurement of LT-specific mRNA levels, the H10407 strain expressed the highest LT concentrations among all tested ETEC strains (Figs. [2C](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). Nonetheless, the amount of LT produced by H10407 \[P*eltAB*(G-14, C-7)\] did not correspond to the amount of transcript when compared with the O88:H25 strains \[P*eltAB*(C-7 T)\] and O159-H21/H17 strains \[P*eltAB*(G-14 T, C-7 T)\]. This observation indicates that the amount of LT produced by ETEC strains is also regulated by posttranscriptional factors. To demonstrate the differential stability behavior of LT produced by different treatments, we measured the amount of cell-associated LT in bacterial cultures treated with a protein synthesis inhibitor. As observed in Fig. [4](#Fig4){ref-type="fig"}, the stability of LT produced by H10407 was significantly lower than those observed with the other tested ETEC strains (Fig. [4A--C](#Fig4){ref-type="fig"}). In addition, incubation of the cells in the presence of a protease inhibitor mixture recovered the stability of LT produced by the H10407 strain (Fig. [4D](#Fig4){ref-type="fig"}). Collectively, these results demonstrated that LT production by ETEC strains is affected both by transcriptional and posttranscriptional elements.Fig. 3Expression of LT by the different ETEC strains. Total LT production was measured by quantitative capture ELISA and normalized by the total protein content of each sample. The values represent the means ± SE from three independent experiments. \* *p* \< 0.05 and \*\**p* \< 0.01, significant differences with regard to the H10407 strain (two-way ANOVA with Tukey's test)Fig. 4Stability of LT produced by different ETEC strains. (**A**-**D**) Determination of LT stability among the tested ETEC strains. Chloramphenicol was used as a protein synthesis inhibitor at 30 (A) or 100 ng/ml (**B--D**), at 6-h culture time (0 h in Figs. **A--C**), in combination (**D**) or not (**A--C**) with protease inhibitor cocktail. (**B**) Evaluation of LT stability of ETEC strains expressing serogroup O159 and LT2 or LT14 in comparison with H10407. Symbols are represented as follows: (■) H10407, (▲) 36III, and (∆) 63 V. (**C**) Evaluation of LT stability of the ETEC strains expressing the serogroup O88 and LT3 or LT5 in comparison with H10407. Symbols are represented as follows: (■) H10407, (▲) 136I, (●) 136II, and (♦) 136III. (**D**) The values correspond to the analysis carried out at 1 h after incubation with the inhibitors. The values represent the average ± SE of the LT relative amounts (%) in comparison to those obtained before treatments for each strain. The assays were repeated three times. \*\**p* \< 0.01 and \*\*\* *p* \< 0.001, significant differences with regard to the H10407 strain (**B-C**) or as indicated by a bracket (**D**); *ns* values without statistically significant differences (two-way ANOVA with Tukey's test)

Discussion {#Sec15}
==========

ETEC strains have shown remarkable heterogeneity regarding genotypes, phenotypic and serological traits, as well as virulence factor profiles \[[@CR7], [@CR10], [@CR13]\]. ETEC may also be distinguished according to the expressed LT type and amount of toxin produced and secreted \[[@CR11], [@CR12], [@CR15], [@CR30]\]. In the present study, we demonstrated that the natural polymorphism in the *eltAB* promoter region may lead to different amounts of transcripts. Additionally, we demonstrated that the final amount of LT produced by the ETEC strain may also be affected, as demonstrated with the reference strain H10407, by the presence of cellular proteases that reduced the stability of synthesized LT. Altogether, our results demonstrate that the genetic diversity observed among the *eltAB* operon of ETEC strains may impact, both at the transcriptional and posttranscriptional levels, the expression of LT.

Bacterial gene expression is controlled by RNA polymerase and regulatory proteins that are dependent on the promoter-sigma factor interaction \[[@CR31]\]. We identified polymorphic sites at the *eltAB* promoter region from different ETEC strains expressing the main LT phylogenetic groups. These mutations were previously shown by Joffré and Sjöling (2016), but it was not possible to correlate them with distinct levels of *eltAB* gene-specific transcripts so far \[[@CR14]\]. Here, we demonstrated differences in transcriptional activity according to the three clusters of mutations found in the promoters of the *eltAB* operon from the ETEC strains using GFP as a reporter gene. The data obtained with the promoter-*gfp* gene fusions were correlated with the distinct patterns of specific mRNA expression exhibited by the strains. The presence of cytosine in the Pribnow box proved to be critical to better the performance of the promoter activity of the *eltAB* operon since the transition of C-7 T diminished GFP and LT expression. Supporting these results, LT2 producers harboring the promoter P*eltAB* (C-7) \[[@CR14]\] showed LT production profiles more similar to the H10407 reference strain \[P*eltAB*(C-7)\] than the LT2-associated ETEC strains evaluated in the present study \[P*eltAB*(C-7 T)\]. In all allelic variants, the − 10 region of the *eltAB* operon remains a highly AT-rich promoter, which may not interfere with promoter opening. However, cytosine instead of thymine at the − 7 position may increase recognition by sigma factor 70 and consequently may improve gene transcription. A similar behavior was observed when promoters that regulate genes belonging to the adaptive response to DNA alkylating agents were mutated \[[@CR32]\]. Together, these results demonstrate that genetic polymorphisms in the promoter impact the transcriptional activity of the *eltAB* operon and contribute to the diversity of LT expression in ETEC.

Although the C-7 T mutation accounts for the decreased expression of *eltAB* in the ETEC strain analyzed, we cannot state that this mutation reduced the affinity of the RNA-polymerase holoenzyme for the − 10 promoter element. We found two open reading frames (ORFs) divergently transcribed to the *eltAB* genes -- ORFs 0680 and 0670. Therefore, the promoter region of the 0670 and even 0680 could be located within the region encompassing − 48 to + 55 relative to the transcription start site (+1) of *eltAB*, which was used in the *gfp* gene constructions. By changing the occupancy of this region with transcriptional factors involved in expression of 0670 and 0680, the C-7 T mutation could alter the accessibility of RNA-polymerase to the − 10 promoter element of the *eltAB* operon instead of a direct effect of this mutation on the binding affinity of the enzyme for the promoter.

Single nucleotide polymorphisms (SNPs) were also observed in the UP element (deletion at position − 51) and region upstream from it among tested ETEC strains. Considering that deletion of the UP element did not interfere with *eltAB* transcription according to Yang and coworkers \[[@CR22]\], the polymorphism in this region of the *eltAB* operon may not be responsible for the variability in the LT-specific mRNA levels among the ETEC strains tested in the present study. On the other hand, the four polymorphic sites upstream of the UP element could contribute to the *eltAB*-specific transcript levels. Additional analyses are required to evaluate the impact of SNPs upstream of the promoter on the diversity of LT expression among the ETEC strains.

Reports in the literature have also demonstrated modulation of LT expression in ETEC by global regulators such as H-NS and CRP proteins \[[@CR19], [@CR22], [@CR24], [@CR25]\]. Although nucleotide substitutions at the H-NS- or CRP-binding sites as well as genes encoding each regulator are rarely found in bacteria sharing close phylogenetic relationships, such mutations may affect the activities of these regulators \[[@CR33]--[@CR35]\]. Data obtained here and by other researchers did not detect polymorphic sites at the CRP-binding sites previously described by Bodero and Munson (2009) \[[@CR14], [@CR24]\]. However, we found variability in the amount of LT produced in the presence or absence of glucose among ETEC strains, indicating that *eltAB* gene repression or activation by CRP is a strain-specific phenomenon (data not shown). Sahl and Rasko (2012) also observed diversity in the effect of glucose and bile salts on the expression of LT-encoding genes upon comparing H10407 and E24377A strains \[[@CR36]\]. Together, these data demonstrate that ETEC strains may diverge regarding the *elt* operon regulation networking under different environmental stimulus. Additionally, our results are in accordance with the previous observation that CRP, in fact, does not bind to the *eltAB* operon and indirectly controls LT expression.

We did not observe a strict correlation between transcription levels of the *eltAB* operon and total amount of LT produced by the tested ETEC strains, indicating that posttranscriptional events were also regulating LT production. One polymorphism was found in the RBS of the *eltB* gene from H10407 and could contribute to compensation at the translation level of the strong transcriptional activity of the *eltAB* operon in comparison with other tested strains. However, additional experiments are required to confirm this observation. On the other hand, we consistently detected instability of H10407-derived LT (LT1) under culture growth conditions, which at least partially explains why H10407 \[P*eltAB*(G-14, C-7)\] expressed four to ten times more *eltAB* transcripts but produced only approximately two times more LT than ETEC strains from serogroups O88 and O159 \[P*eltAB*(C-7 T) and P*eltAB*(G-14 T, C-7 T), respectively\]. The stability of this protein was recovered under treatment with protease inhibitors, indicating strong control of LT production by the cellular protein degradation machinery in H10407. This susceptibility to proteolysis does not seem to be due to LT type and may be ascribed to specificities of the proteolytic machinery of H10407. The proteolytic routes have been reported in the literature particularly the control of expression and activity of virulence and physiology regulators in bacteria \[[@CR37], [@CR38]\]. However, proteolysis of LT as regulatory mechanism of expression has not been described previously. Collectively, the results showed in the present study demonstrate that LT production is regulated by both transcriptional and posttranscriptional mechanisms of protein regulation, allowing the control of overexpression of LT by some ETEC strains.

Despite the natural diversity of ETEC, clonal relationships among some strains have been demonstrated by phenotypic and genotypic methods \[[@CR6], [@CR7], [@CR10], [@CR13]\]. As such, ETEC strains sharing determined serotypes or serogroups have shown the same pattern of virulence factors; for example, the O6:H16 strains are CFA-II^+^LT^+^ST^+^ \[[@CR7]\]. Here, we observed that strains sharing the same serogroup (O88 or O159) and expressing phylogenetically clustered LTs (LT3/LT5 or LT2/LT14, respectively) show similar patterns of LT production and the same allelic variant in the *etxAB* promoter \[P*eltAB*(C-7 T) or P*eltAB*(G-14 T, C-7 T), respectively\] in comparison with reference ETEC H10407 \[P*eltAB*(G-14, C-7)\]. In fact, such lineages sharing the same serogroup present a close genetic relationship defined by the MLEE, PFGE, and RAPD profiles \[[@CR10]\]. Additionally, our results together with those reported by Joffré and Sjöling (2016) \[[@CR14]\] reveal that LT2-producing strains with different genetic backgrounds show distinct LT production profiles. In fact, previous reports at the global or local geographic scale have demonstrated the diversity of LT expression among ETEC strains, even among strains expressing the same LT type \[[@CR11], [@CR12], [@CR15]\].

Collectively, these findings suggest that the determined allelic variants of the *eltAB* genes encoding phylogenetically related LTs may have been distributed by horizontal transfer to *E. coli* strains with different genetic backgrounds and that the production of the toxin would be impacted by specificities of the regulatory regions in the *eltAB* operon and, particularly, by strain-specific characteristics of the bacterial cellular machinery. Considering that the level of LT production and secretion may contribute to the severity of diarrhea, further studies focused on the diversity of LT expression, and the virulence of the strain shall contribute to the design of more rational preventive and therapeutic approaches to control diarrhea associated with ETEC infection.
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